Renaissance Technologies’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-131,100
Closed -$2.64M 4359
2021
Q3
$2.64M Sell
131,100
-100
-0.1% -$2.02K ﹤0.01% 1882
2021
Q2
$4.9M Sell
131,200
-16,445
-11% -$614K 0.01% 1649
2021
Q1
$3.78M Sell
147,645
-539,233
-79% -$13.8M ﹤0.01% 1825
2020
Q4
$15.1M Sell
686,878
-461,022
-40% -$10.2M 0.02% 905
2020
Q3
$20.7M Buy
1,147,900
+237,700
+26% +$4.28M 0.02% 722
2020
Q2
$23.1M Buy
910,200
+151,100
+20% +$3.84M 0.02% 739
2020
Q1
$13.9M Sell
759,100
-233,300
-24% -$4.29M 0.01% 961
2019
Q4
$21.9M Buy
992,400
+507,000
+104% +$11.2M 0.02% 954
2019
Q3
$6.97M Buy
+485,400
New +$6.97M 0.01% 1618
2018
Q3
Sell
-71,100
Closed -$871K 3644
2018
Q2
$871K Sell
71,100
-218,300
-75% -$2.67M ﹤0.01% 2652
2018
Q1
$2.77M Sell
289,400
-270,900
-48% -$2.59M ﹤0.01% 2156
2017
Q4
$5.06M Buy
560,300
+90,700
+19% +$819K 0.01% 1796
2017
Q3
$2.7M Buy
469,600
+26,500
+6% +$152K ﹤0.01% 2129
2017
Q2
$1.41M Buy
443,100
+24,600
+6% +$78K ﹤0.01% 2436
2017
Q1
$1.42M Buy
418,500
+9,818
+2% +$33.4K ﹤0.01% 2410
2016
Q4
$1.18M Buy
408,682
+84,682
+26% +$244K ﹤0.01% 2481
2016
Q3
$1.91M Buy
324,000
+248,400
+329% +$1.46M ﹤0.01% 2217
2016
Q2
$227K Buy
75,600
+45,700
+153% +$137K ﹤0.01% 3013
2016
Q1
$160K Buy
+29,900
New +$160K ﹤0.01% 3145
2015
Q3
Sell
-61,700
Closed -$861K 3442
2015
Q2
$861K Buy
61,700
+49,100
+390% +$685K ﹤0.01% 2526
2015
Q1
$303K Buy
+12,600
New +$303K ﹤0.01% 2764